• to lower the risk of major cardiovascular (coronary heart and blood vessel) complications in Older people with form two diabetes and cardiovascular disease In October 2024, Novo Nordisk posted a study on scientific journal Nature a few novel glucose-delicate insulin NNC2215 which can m